Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Woisetschlaeger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Virology|September 1, 1996
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell linesM T Puglielli, M Woisetschlaeger, S H Speck
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytesM Woisetschlaeger, J L Strominger, S H Speck
The EMBO Journal|July 1, 1990
Alternative splicing dictates translational start in Epstein-Barr virus transcriptsR P Rogers, M Woisetschlaeger, S H Speck
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytesB C Schaefer, M Woisetschlaeger, J L Strominger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytesM Woisetschlaeger, C N Yandava, L A Furmanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infectionM Woisetschlaeger, X W Jin, C N Yandava, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Virology|September 1, 1996
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell linesM T Puglielli, M Woisetschlaeger, S H Speck
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytesM Woisetschlaeger, J L Strominger, S H Speck
The EMBO Journal|July 1, 1990
Alternative splicing dictates translational start in Epstein-Barr virus transcriptsR P Rogers, M Woisetschlaeger, S H Speck
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytesB C Schaefer, M Woisetschlaeger, J L Strominger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytesM Woisetschlaeger, C N Yandava, L A Furmanski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infectionM Woisetschlaeger, X W Jin, C N Yandava, et al.
Pageof 1